Krystal Biotech (KRYS) Times Interest Earned (2021)
Krystal Biotech recorded quarterly Times Interest Earned of -$9.62 in Q1 2021.
Krystal Biotech's Times Interest Earned history runs 1 years deep, the most recent figure standing at -$9.62 for Q1 2021.
- In Q1 2021, Times Interest Earned changed N/A year-over-year to -$9.62; the TTM figure through Dec 2021 stood at -$45.76 (changed N/A YoY), while the FY2021 annual figure was -$45.76, changed N/A from the prior year.
- Times Interest Earned came in at -$9.62 for Q1 2021 at Krystal Biotech.
- In the past five years, Times Interest Earned ranged from a high of -$9.62 in Q1 2021 to a low of -$9.62 in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 3.88 |
| 10 | Krystal Biotech | 9.05 Bn | 8.23 Bn | 110.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | -9.62 |